1. Home
  2. APLS vs CATY Comparison

APLS vs CATY Comparison

Compare APLS & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • CATY
  • Stock Information
  • Founded
  • APLS 2009
  • CATY 1962
  • Country
  • APLS United States
  • CATY United States
  • Employees
  • APLS N/A
  • CATY N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • CATY Major Banks
  • Sector
  • APLS Health Care
  • CATY Finance
  • Exchange
  • APLS Nasdaq
  • CATY Nasdaq
  • Market Cap
  • APLS 3.5B
  • CATY 3.4B
  • IPO Year
  • APLS 2017
  • CATY N/A
  • Fundamental
  • Price
  • APLS $23.80
  • CATY $48.31
  • Analyst Decision
  • APLS Buy
  • CATY Hold
  • Analyst Count
  • APLS 20
  • CATY 5
  • Target Price
  • APLS $33.47
  • CATY $50.00
  • AVG Volume (30 Days)
  • APLS 2.3M
  • CATY 425.2K
  • Earning Date
  • APLS 11-04-2025
  • CATY 10-21-2025
  • Dividend Yield
  • APLS N/A
  • CATY 2.82%
  • EPS Growth
  • APLS N/A
  • CATY N/A
  • EPS
  • APLS N/A
  • CATY 4.14
  • Revenue
  • APLS $754,649,000.00
  • CATY $704,760,000.00
  • Revenue This Year
  • APLS $22.11
  • CATY $17.40
  • Revenue Next Year
  • APLS N/A
  • CATY $6.77
  • P/E Ratio
  • APLS N/A
  • CATY $11.67
  • Revenue Growth
  • APLS 20.02
  • CATY N/A
  • 52 Week Low
  • APLS $16.10
  • CATY $36.06
  • 52 Week High
  • APLS $35.72
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • APLS 47.98
  • CATY 48.11
  • Support Level
  • APLS $21.07
  • CATY $47.23
  • Resistance Level
  • APLS $23.50
  • CATY $48.81
  • Average True Range (ATR)
  • APLS 0.80
  • CATY 1.01
  • MACD
  • APLS -0.03
  • CATY -0.16
  • Stochastic Oscillator
  • APLS 78.45
  • CATY 34.29

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: